Not finding it? Sign in to also search OpenAlex live.
-
Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Jean‐Jacques Kiladjian, Alberto Álvarez‐Larrán, Konstanze Döhner
2citations -
Metal Electroplating/Stripping and 4D STEM Analysis Revealed by Liquid Phase Transmission Electron Microscopy2023 Microscopy and Microanalysis article Engineering Advanced battery technologies research Open access
Eva Bladt, Yevheniy V. Pivak, Junbeom Park, Dieter Weber, Janghyun Jo, Shibabrata Basak, +2 more
1citations -
No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials2026 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Sofía Ramiro, Corine Gaillez, Uta Kiltz, Lianne S. Gensler, Chaitali Babanrao Pisal, Jürgen Braun, +1 more
0citations -
Interpretation of Chemistry, Hematology and Coagulation Laboratory Results in Early‐Phase Clinical Pharmacology Trials; a Retrospective Analysis Based on the Placebo Arm of Randomized‐Controlled Trials2026 Clinical and Translational Science article Medicine Clinical Laboratory Practices and Quality Control Open access
Jannik Rousel, Tessa Niemeyer‐van der Kolk, Matthijs Moerland, Robert Rißmann, Naomi B. Klarenbeek, Maurits F. J. M. Vissers, +1 more
0citations -
#2651 Sustainability and depth of UPCR reduction in patients with primary IgAN treated with nefecon: a secondary analysis of the Phase 3 NefIgArd trial2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Heather N. Reich, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, Vladimı́r Tesař, +4 more
0citations -
P319 Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Teruaki Kobayashi, AU Dignass, Xavier Roblin, Y Fujitani, Alessandra Faria Oortwijn, C Jamoul, +1 more
0citations -
Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)2025 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Britta Hoechsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Joerg Westermann, Beatrice Drexler, +10 more
0citations -
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne Post, Stephanie M. de Boer, Melanie E. B. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, +23 more
48citations -
Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Final Progression-Free Survival Analysis of Part 1 of an Open-Label, Multicenter, Randomized, Phase 3 Trial (GMMG-HD7)
Hartmut Goldschmidt, Uta Bertsch, Ema Požek, Axel Benner, Roland R. Fenk, Britta Besemer, +26 more
1citations -
The Near Infrared Imager and Slitless Spectrograph for JWST. V. Kernel Phase Imaging and Data Analysis2023 Publications of the Astronomical Society of the Pacific article Physics and Astronomy Adaptive optics and wavefront sensing Open access
Jens Kammerer, Thomas Vandal, Deepashri Thatte, Frantz Martinache, Anand Sivaramakrishnan, Alexander Chaushev, +22 more
17citations -
Capabilities of Auto-encoders and Principal Component Analysis of the reduction of microstructural images; Application on the acceleration of Phase-Field simulations2022 Computational Materials Science article Physics and Astronomy Model Reduction and Neural Networks Open access
Seifallah Fetni, Thinh Quy Duc Pham, Truong‐Vinh Hoang, Hoang Son Tran, Laurent Duchêne, Xuan-Van Tran, +1 more
29citations -
LY13 A confirmatory phase III multicentre, randomized, double-blind, placebo-controlled study of the efficacy of topical HyBryte™ (hypericin sodium) and visible-light activation for the treatment of cutaneous T-cell lymphoma: interim analysis results of primary efficacy and safety for FLASH22026 British Journal of Dermatology conference-abstract Medicine Cutaneous lymphoproliferative disorders research
Julia Jane Scarisbrick, Maarten H. Vermeer, Martine Bagot, Pablo Ortiz‐Romero, Pietro Quaglino, Ellen J. Kim, +1 more
0citations -
Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA–IIA Mycosis Fungoides
Christiane Querfeld, Julia Jane Scarisbrick, Chalid Assaf, Emmanuella Guenova, Martine Bagot, Pablo Luis Ortiz-Romero, +3 more
20citations -
First safety analysis of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluoruracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC).2025 Journal of Clinical Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Dirk Waldschmidt, Nam Gyu Im, Alexander Ioannis Damanakis, Thomas Schmidt, Albrecht Meyer zu Schwabedissen, Alexander Quaas, +13 more
0citations -
POS0893 EFFICACY OF SECUKINUMAB ACROSS THE AXIAL SPONDYLOARTHRITIS SPECTRUM AMONG PATIENTS GROUPED BY AGE (≥40 YEARS VS <40): A POST HOC ANALYSIS OF 6 PHASE 3 TRIALS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Sofía Ramiro, Corine Gaillez, Uta Kiltz, Lianne S. Gensler, Chaitali Babanrao Pisal, J. Braun, +1 more
0citations -
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept2022 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Joshua F. Baker, Philip G. Conaghan, Paul E. Emery, Tom W. J. Huizinga, Yedid Elbez, Subhashis Banerjee, +1 more
18citations -
Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Alone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma or for Whom Transplant Is Not Planned As Initial Therapy: Analysis of Minimal Residual Disease in the Cepheus Trial
Sonja Zweegman, Thierry T.F. Facon, Vânia Hungria, Nizar Jacques Bahlis, Christopher Paul Venner, Marc Justin Braunstein, +22 more
13citations -
Selinexor Efficacy and Safety Are Independent of Renal Function in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis from the Pivotal Phase 2b Sadal Study
Michael W. Schuster, Miguel Ángel Canales, Jason R. Westin, Josée M. Zijlstra, George Follows, Reem Karmali, +32 more
3citations -
Nucleotidomics: Extending Reversed-Phase Metabolomics to Untargeted Nucleotide Analysis2026 ChemRxiv preprint Biochemistry, Genetics and Molecular Biology Metabolomics and Mass Spectrometry Studies
Krzysztof Urbanowicz, Oliwier Krajewski, Aleksandra E. Bogucka, Mikołaj Opiełka, Cecilia Bergonzini, Jacek Turyn, +5 more
0citations -
Comparative Analysis of Phase-Field and Intrinsic Cohesive Zone Models for Fracture Simulations in Multiphase Materials with Interfaces: Investigation of the Influence of the Microstructure on the Fracture Properties
Rasoul Najafi Koopas, Shahed Rezaei, Natalie Rauter, Richard Ostwald, Rolf Lammering
7citations -
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial2021 Nature Medicine article Immunology and Microbiology Mast cells and histamine Open access cited by 1 patent
Jason R. Gotlib, Andreas Reiter, Deepti H. Radia, Michael W. Deininger, Tracy I. George, Jens Panse, +18 more
151citations